CRI vs DGX · P/E 7.0, rev $1.30B vs P/E 22, rev $5.94B
Carter’s Inc (CRI) versus Quest Diagnostics Incorporated (DGX) — a side-by-side from cached financials, not a winner call.
Carter’s Inc (CRI) is a apparel retail company listed on US.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Latest reported CRI revenue for 2026-07-04 was $1.30B. Net income was $119.3M. Revenue was up 90.4% from 2026-04-04 to 2026-07-04. CRI currently screens at market cap $1.15B and trailing P/E 7.0.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
CRI currently screens at market cap $1.15B and trailing P/E 7.0. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Not investment advice. Open the CRI and DGX stock pages for the full models.
Not investment advice.